Answer
Daridorexant hydrochloride has a terminal half-life of approximately 8 hours; in moderate hepatic impairment, half-life increased 2.1-fold compared with healthy subjects after a single 25 mg dose, while severe hepatic impairment has not been studied.
Sources for this answer
- QUVIVIQ 50 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 5Document updated
Sources checked